RY 174.39 2.4016% SHOP 149.115 2.5974% TD-PFM 24.63 -0.0811% TD-PFL 24.7 0.2028% TD 78.325 0.1214% ENB 60.6 1.3039% BN 80.4 1.9787% TRI 226.27 0.7525% CNQ 48.285 2.2771% CP 104.53 1.6038% CNR 151.74 1.5459% BMO 132.69 0.9203% BNS 78.845 0.1715% CSU 4600.2002 2.157% CM 91.15 0.474% MFC 45.79 1.6878% ATD 78.38 1.5285% NGT 60.14 0.0499% TRP 70.15 1.977% SU 57.44 0.5954%
Last update at 2024-01-23T15:38:00Z
Invesque Inc. Announces Results of Voting at Annual Meeting of Shareholders
Thu 22 Jun 23, 08:00 PMInvesque Inc. Reports First Quarter 2023 Results
Thu 11 May 23, 03:58 AMInvesque Inc. Reports Fourth Quarter and Full-Year 2022 Results
Thu 16 Mar 23, 12:11 AMBreakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|
Type | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Income before tax | -43.13700M | -12.23500M | -190.94800M | -5.42600M |
Minority interest | - | - | - | - |
Net income | -48.81000M | -12.23500M | -184.00400M | -5.35900M |
Selling general administrative | 32.58M | 19.00M | 18.70M | 18.09M |
Selling and marketing expenses | - | - | - | - |
Gross profit | 95.59M | 90.97M | 108.39M | 95.31M |
Reconciled depreciation | 16.52M | 22.15M | 48.57M | 14.44M |
Ebit | 38.71M | 46.33M | 8.21M | 68.85M |
Ebitda | 6.34M | 40.75M | -105.51400M | 48.85M |
Depreciation and amortization | - | - | - | - |
Non operating income net other | - | - | - | - |
Operating income | 30.73M | 52.35M | 20.99M | 64.86M |
Other operating expenses | - | - | - | - |
Interest expense | 32.96M | 30.83M | 36.87M | 39.84M |
Tax provision | -1.12700M | 0.00000M | -6.94400M | -0.06700M |
Interest income | 1.54M | 1.47M | 2.98M | 3.66M |
Net interest income | -37.22000M | -34.54000M | -37.54900M | -40.08200M |
Extraordinary items | - | - | - | - |
Non recurring | - | - | - | - |
Other items | - | - | - | - |
Income tax expense | -1.12700M | - | -6.94400M | -0.06700M |
Total revenue | 198.03M | 210.45M | 217.39M | 144.69M |
Total operating expenses | 167.30M | 158.10M | 196.39M | 79.83M |
Cost of revenue | 102.44M | 119.48M | 108.99M | 49.38M |
Total other income expense net | -36.65000M | -30.04100M | -174.39200M | -30.20600M |
Discontinued operations | -6.80000M | -5.71200M | -5.71200M | -5.71200M |
Net income from continuing ops | -42.01000M | -12.23500M | -184.00400M | -5.35900M |
Net income applicable to common shares | -48.81000M | -12.23500M | -184.00400M | -5.35900M |
Preferred stock and other adjustments | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|
Type | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Total assets | 1097.34M | 1301.01M | 1498.42M | 1630.74M |
Intangible assets | - | - | - | - |
Earning assets | - | - | - | - |
Other current assets | 36.04M | 37.06M | 11.21M | 18.39M |
Total liab | 865.69M | 1014.75M | 1205.10M | 1150.59M |
Total stockholder equity | 231.65M | 286.26M | 293.33M | 480.14M |
Deferred long term liab | - | - | - | - |
Other current liab | 7.87M | 3.79M | 4.97M | 6.37M |
Common stock | 508.96M | 512.00M | 509.20M | 504.56M |
Capital stock | 594.35M | 597.39M | 594.59M | 589.95M |
Retained earnings | -370.07700M | -321.26700M | -309.03200M | -114.90800M |
Other liab | 1.67M | 4.81M | 14.35M | 21.48M |
Good will | - | - | - | - |
Other assets | 19.65M | 20.06M | 16.90M | 37.41M |
Cash | 27.58M | 19.37M | 34.13M | 11.84M |
Cash and equivalents | - | - | - | - |
Total current liabilities | 483.13M | 91.06M | 78.32M | 95.91M |
Current deferred revenue | - | - | - | - |
Net debt | 737.88M | 874.38M | 1018.34M | 1001.64M |
Short term debt | - | - | - | - |
Short long term debt | 444.29M | 55.35M | 40.62M | 57.59M |
Short long term debt total | - | - | - | - |
Other stockholder equity | 6.97M | 11.78M | 7.37M | 4.70M |
Property plant equipment | 935.80M | 1149.82M | 1335.73M | 1431.78M |
Total current assets | 81.76M | 76.55M | 74.83M | 52.43M |
Long term investments | 49.08M | 50.44M | 65.26M | 99.32M |
Net tangible assets | 146.26M | 202.92M | 207.94M | 394.75M |
Short term investments | - | - | - | - |
Net receivables | 18.14M | 20.12M | 29.49M | 22.21M |
Long term debt | 321.17M | 838.40M | 1011.85M | 955.88M |
Inventory | - | - | - | - |
Accounts payable | 13.09M | 17.36M | 17.71M | 18.89M |
Total permanent equity | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - |
Accumulated other comprehensive income | - | - | - | - |
Additional paid in capital | - | - | - | - |
Common stock total equity | - | - | - | - |
Preferred stock total equity | - | - | - | - |
Retained earnings total equity | - | - | - | - |
Treasury stock | - | - | - | - |
Accumulated amortization | - | - | - | - |
Non currrent assets other | 1.58M | 2.23M | 2.77M | 4.56M |
Deferred long term asset charges | - | - | - | - |
Non current assets total | 1015.58M | 1224.46M | 1423.59M | 1578.31M |
Capital lease obligations | - | - | - | - |
Long term debt total | - | - | - | - |
Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
---|---|---|---|---|
Type | yearly | yearly | yearly | yearly |
Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
Investments | 20.70M | 11.80M | 2.92M | 14.51M |
Change to liabilities | -2.34900M | -0.66400M | 0.42M | 0.04M |
Total cashflows from investing activities | 138.09M | 122.02M | 3.52M | -309.82200M |
Net borrowings | -130.11200M | -152.27800M | 5.95M | 300.25M |
Total cash from financing activities | -141.79400M | -155.76100M | -6.31200M | 278.51M |
Change to operating activities | 0.05M | 2.89M | 0.52M | 5.34M |
Net income | -48.81000M | -12.23500M | -184.00400M | -5.35900M |
Change in cash | 8.21M | -14.76400M | 22.30M | -15.14000M |
Begin period cash flow | 19.37M | 34.13M | 11.84M | 26.98M |
End period cash flow | 27.58M | 19.37M | 34.13M | 11.84M |
Total cash from operating activities | 11.91M | 18.97M | 25.09M | 16.17M |
Issuance of capital stock | - | - | 0.00000M | 14.55M |
Depreciation | 16.52M | 22.15M | 48.57M | 14.44M |
Other cashflows from investing activities | 0.08M | 0.23M | 0.06M | -9.39300M |
Dividends paid | - | - | 9.98M | 32.51M |
Change to inventory | - | - | - | - |
Change to account receivables | -8.59300M | -7.03400M | -12.34400M | -16.06600M |
Sale purchase of stock | -10.60100M | - | -0.14800M | -0.53000M |
Other cashflows from financing activities | -1.08100M | -3.48300M | -2.13300M | -3.25400M |
Change to netincome | 50.73M | 8.46M | 167.48M | 13.65M |
Capital expenditures | 6.52M | 7.58M | 11.27M | 235.43M |
Change receivables | - | - | - | - |
Cash flows other operating | - | - | - | - |
Exchange rate changes | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - |
Change in working capital | -10.89100M | -5.10400M | -11.40200M | -10.68500M |
Stock based compensation | - | - | - | - |
Other non cash items | 41.75M | 42.83M | 49.62M | 33.33M |
Free cash flow | 5.40M | 11.11M | 13.82M | -219.26300M |
Sector: Real Estate Industry: Real Estate Services
Company | Change (CAD) | Price (CAD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
IVQ-U Invesque Inc |
0.06 31.43% | 0.23 | - | - | 0.07 | 0.15 | 3.55 | -41.6379 |
FSV FirstService Corp |
3.47 1.32% | 266.76 | 78.12 | 33.67 | 2.38 | 7.35 | 1.99 | 21.75 |
CIGI Colliers International Group Inc Bats |
1.45 0.73% | 200.34 | 47.88 | 21.83 | 2.39 | 6.26 | 2.22 | 16.44 |
BPO-PC Brookfield Office Properties Inc Pref C |
0.34 2.54% | 13.75 | 2.86 | - | 2.38 | - | ||
BPO-PA Brookfield Office Properties Inc Pref A |
0.51 5.10% | 10.51 | 2.21 | - | 1.84 | - |
Invesque Inc. operates as a health care real estate investment company. Its portfolio includes investments in independent living, assisted living, memory care, skilled nursing, transitional care, and medical office properties. As of March 15, 2023, the company owned a portfolio of 76 properties, such as 56 assisted living and memory care facilities, 13 skilled nursing facilities, 4 transitional care properties, and 3 medical office buildings in the United States; and 4 seniors housing and care facilities in Canada. It also includes investments in owner occupied seniors housing properties, including the ownership of real estate properties, as well as provides management services. The company was formerly known as Mainstreet Health Investments Inc. and changed its name to Invesque Inc. in January 2018. Invesque Inc. was incorporated in 2007 and is headquartered in Vancouver, Canada.
333 Bay Street, Toronto, ON, Canada, M5H 2S7
Name | Title | Year Born |
---|---|---|
Mr. Scott Eric White CPA | Chairman & CEO | 1974 |
Mr. Scott Higgs | Chief Financial Officer | 1983 |
Mr. Adlai Chester | Chief Investment Officer & Non-Independent Director | 1982 |
Mr. Jim Rees | Director of Accounting | NA |
Mr. Vineet P. Bedi C.F.A. | Chief Strategy Officer & IR | 1983 |
Christine Johnson | Director of Marketing | NA |
Ms. Julie Michael | Exec. Assistant & HR Coordinator | NA |
Mr. Dennis Dechow | Sr. VP of Asset Services | NA |
Mr. Bryan E. Hickman | Sr. VP of Investments | NA |
Mr. Quinn Haselhorst | Sr. VP of Fin. | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.